Cambridge ideas change the world

Illumina Feb 2017 Recruitment Gateway Candidate Evening February 2017 Train your Chimp
Cambridge Network is a membership organisation based in the vibrant high technology cluster of Cambridge, UK. We bring people together - from business and academia - to meet each other and share ideas, encouraging collaboration and partnership for shared success.

News


Residents’ views sought on ambitious vision for improving community facilities and services

Cambridge City Council is asking for the views of local people on its draft proposals for an ambitious vision for council-owned community facilities and the services they provide.

20/02/2017Read in full

£25,000 award will make a splash for young hospice users in East Anglia

East Anglia’s Children’s Hospices (EACH) has secured £25,000 to refurbish its hydrotherapy pool in Milton, after winning a national award.

20/02/2017Read in full

Industrial strategy: how it relates to the Cambridge commercial property market

Commenting on the government's Industrial Strategy green paper issued last month, Philip Woolner, head of Commercial Agency at Cheffins, explains how he believes it will relate to Cambridge and the commercial property market.

20/02/2017Read in full

First British robotics seed fund launches

High Growth Robotics Limited, based at Adastral Park, Martlesham Heath near Ipswich, has announced the launch of the British Robotics Seed Fund – the first investment fund specialising in UK-based robotics start-ups.

20/02/2017Read in full

Startups urged to enter EDF Pulse Awards

Leading energy company EDF seeks applications from Cambridge organisations for the 2017 edition of its open innovation competition EDF Pulse, aimed at innovative European startups in smart city, smart home, smart business and smart health.

20/02/2017Read in full

Coal, fuel of the future

Coal will continue to be a major part of the energy mix for decades to come, but we need to use it more efficiently, suggests The Scientific Alliance.

17/02/2017Read in full

Lynparza meets primary endpoint in Phase III trial in BRCA-mutated metastatic breast cancer

AstraZeneca’s breast cancer treatment, Lynparza (olaparib), provided a statistically-significant improvement in progression-free survival compared to chemotherapy in the first positive randomised trial to evaluate the efficacy and safety of a PARP inhibitor beyond ovarian cancer.

17/02/2017Read in full

Daniel Zeichner MP discusses future of dementia research with leading charity

Protecting the future of dementia research in a post-Brexit Britain was on the agenda when Cambridge MP Daniel Zeichner visited Alzheimer’s Research UK this week.

17/02/2017Read in full

Art exhibition aims to combat mental health stigma

An art exhibition featuring portraits of people recovering from mental health conditions is to open in Cambridge.

17/02/2017Read in full

Learn about small self-administered schemes (SSAS) in 60 seconds

Mattioli Wood's Wealth Management Director, Alex Brown, provides a 60-second overview of small self-administered schemes (SSAS) in the second of the firm's brand new series of educational videos.

17/02/2017Read in full